Optimise access for medical devices and diagnostics into European markets and support commercial success

Your trusted partner for the full market introduction process – from evidence generation to pricing, market access, and reimbursement.

IGES MedTech optimises time to market across European markets. With a proven track record in evidence generation, market access, and reimbursement, we provide strategic guidance, consultation, and coaching, along with hands-on execution tailored to your device’s unique value. Together, we help bring life-changing innovations to patients while ensuring success across diverse healthcare systems.

"Medical devices and diagnostics have the potential to change lives. At IGES MedTech, we take pride in guiding our partners - from emerging startups to established global leaders - through Europe’s healthcare systems. With a focus on speed, precision, and tailored strategies, we help bring innovations to patients faster while maximising their impact on healthcare systems.“

Mattias Kyhlstedt, Regional Director European Strategy & Nordics

Our Comprehensive Services for Medical Device Success Across Europe

Tailored solutions to guide your medical device from evidence generation to reimbursement across Europe.

Successfully introducing a medical device, digital health application, or diagnostic solution to European markets requires expertise across multiple disciplines. At IGES MedTech, our comprehensive services are designed to support your journey at every stage - from strategy and evidence generation to market access, reimbursement, and stakeholder engagement. Explore our tailored solutions below to see how we can help you succeed across Europe.

Our Comprehensive Services Market Access Strategy Stakeholder Engagement Real World Evidence Reimbursement & Innovation Funding HTA Value Communication & Health Economics Evidence Generation
Our Comprehensive Services Market Access Strategy Stakeholder Engagement Real World Evidence Reimbursement & Innovation Funding HTA Value Communication & Health Economics Evidence Generation

Market Access Strategy

  • Reimbursement analysis
  • Prioritising high-potential markets and launch sequencing
  • Reimbursement and/or innovation pathway alignment strategies
  • Evidence strategy

> More

Stakeholder Engagement

  • Mapping and engaging with key decision makers
  • Facilitating structured stakeholder discussions - Consensus Meetings
  • Collaborating with healthcare organisations
  • Tailoring evidence-based communication

> More

Real World Evidence

  • Find the right data and setting
  • Designing observational studies
  • Incorporating real-world economic insights
  • Aligning RWE with HTA needs
  • Crafting Decision Maker Communication Dossiers

> More

Reimbursement & Innovation Funding

  • Mapping national reimbursement pathways
  • Reimbursement analysis
  • Engaging Decision Makers

> More

HTA

  • EU HTA coordination
  • HTA dossier development
  • Evidence requirements
  • Comparative cost-effectiveness modelling
  • Localised stakeholder consultation

> More

Value Communication & Health Economics

  • Crafting evidence-driven value propositions
  • Demonstrating impact with clear narratives
  • Aligning value communication with reimbursement needs
  • Supporting pricing discussions with cost-effectiveness insights

> More

Evidence Generation

  • Identifying clinical and economic evidence requirements
  • Addressing evidence gaps with targeted strategies
  • Integrating Real-World Evidence into evidence plans
  • Preparing for EU HTA submissions for selected MedTech products

> More

Your Medical Device and Diagnostic Journey to Success – Step by Step

IGES MedTech Value Chain

1. Strategic Planning & Market Assessment

- Understand the reimbursement landscape for the technology.
- Define the pathway to establish/change reimbursement and market access.
- Identify the type of evidence required.
- Explore routes to special funding for innovative solutions and government-sponsored clinical trials.
- Develop a strategic plan to optimise evidence development and align country-specific activities.

2. Evidence Strategy

- Define specific clinical and economic evidence requirements for the device in selected markets.
- Evaluate requirements with decision-makers to confirm an evidence strategy.
- Optimise the use of real-world evidence and pragmatic trials.

3. Value Communication and Health Economics

- Development of a Core Value Dossier.
- Health Economic Modelling.
- Value communication.
- Interactive dashboards for a compelling value story.

4. Local Reimbursement Execution and Stakeholder Engagement

- Coordinate activities across countries.
- Process local reimbursement and HTA applications.
- Manage stakeholders throughout the process.
- Maintain continuous collaboration through consultation and coaching to demonstrate the impact and delivery of innovation to healthcare markets.

5. Real-World Evidence

- Execution of real-world evidence studies in Germany, France, the UK, and Sweden.

Explore Our Specialised Expertise Across MedTech Fields

From devices to diagnostics, IGES MedTech brings in-depth knowledge across diverse therapeutic and device areas to help your solution succeed.

Successfully navigating the European market requires a tailored approach that aligns with both the specific nature of your technology and the therapeutic area it serves. At IGES MedTech, we support medical device companies across all key categories - from digital health and hospital-based solutions to capital equipment and in-vitro diagnostics. In addition, our deep expertise spans a wide range of therapeutic fields, enabling us to provide targeted strategies that meet the unique market access, reimbursement, and regulatory requirements for each specialty. Whether you are launching a new device, a digital health application, or a diagnostic solution, our expert team ensures your innovation reaches patients across Europe with speed and precision.

Different Types of Solutions We Support

Our expertise covers all major MedTech categories, providing the strategies needed to bring your innovation to market.

Digital Health

Digital Health

e.g. DTx, remote monitoring, and virtual healthcare

Hospital-Based Products

Hospital-Based Products

Devices and solutions designed for clinical settings

In-Vitro Diagnostics (IVD)

In-Vitro Diagnostics (IVD)

Laboratory-based and point-of-care diagnostic technologies

Capital Equipment

Capital Equipment

Imaging, robotics, and high-investment MedTech infrastructure

Medical Aids

Medical Aids

Assistive devices, prosthetics, and rehabilitation solutions

Therapeutic Areas Where We Bring Proven Expertise

Beyond supporting different MedTech solutions, we bring in-depth knowledge across specialised therapeutic fields, ensuring tailored strategies that align with clinical demands, healthcare priorities, and market access requirements.

Diabetes

Diabetes

Bariatrics

Bariatrics

Cardiovascular

Cardiovascular

Clinical Genetics

Clinical Genetics

Ear, Nose, and Throat (ENT)

Ear, Nose, and Throat (ENT)

Musculoskeletal

Musculoskeletal

Neurology

Neurology

Oncology

Oncology

Ophthalmology

Ophthalmology

Urology

Urology

Vascular

Vascular

Wound Care

Wound Care

A Team You Can Rely On

Experts combining decades of experience in consulting, industry, and academia.

Experts

20+

Experts

Dedicated to bringing solutions to European markets.

Years of Experience

15+

Years of Experience

Supporting MedTech success since 2007.

Completed Projects

3,000+

Completed Projects

Delivered with speed and precision.

Countries Covered

20+

Countries Covered

Projects executed across Europe's healthcare systems.

With over 15 years of expertise and 3,000+ successful projects, IGES MedTech has become a trusted partner for market access and health economics in Europe. Our team combines strategic insight across European, national, and local markets with expertise to deliver tailored solutions that help bring your solution to market.

Why Innovators Choose IGES MedTech

Deep Local Expertise with a Strategic Edge

We combine hands-on expertise in local market access execution with the ability to integrate this knowledge into a cohesive, forward-thinking strategy - ensuring seamless entry into European markets.

Robust Evidence Strategies for Market Success

We develop comprehensive clinical and economic evidence strategies, tailored to the specific requirements of each country, supporting market access and commercial success.

Optimised Market Entry for Maximum Impact

With our deep understanding of how different types of medical technologies fit within national reimbursement systems, we optimise launch sequencing to maximise market potential.

A Partner for Every Step - or Just One

Whether you need full-service support or targeted expertise, IGES MedTech adapts to your needs. From evidence generation to reimbursement, we’re with you every step of the way.

Proven Success in Local Markets

Our unmatched track record in securing reimbursement across Europe’s healthcare systems ensures your innovation reaches the right markets efficiently and effectively.